ECHA: 69% Of 2010 REACH Dossiers Noncompliant Among 5% Checked
This article was originally published in The Rose Sheet
The European Chemicals Agency urges stakeholders to put the outcome of its compliance checks in perspective, as it targeted dossiers submitted against the 2010 REACH deadline based on initial screenings that identified possible shortcomings. Data regarding substance identification/composition and rationales for missing safety information were often insufficient in dossiers it examined, ECHA says.
You may also be interested in...
ECHA sees some improvement in REACH dossiers, but familiar problems remain, according to its 2012 Progress Report. The agency notes that 2012 was a “crucial” year as it completed its examination of all testing proposals received for the first REACH deadline in 2010.
Beiersdorf’s Long Court Battle Over Nivea ‘Drug’ Claims May Be Ending; In Similar Case, L’Oreal May Settle
The Beiersdorf and L’Oreal cases, both pending in California federal courts, have important implications for the cosmetics industry and its use of benefit claims that test statutory boundaries between unapproved drug products and cosmetics.
Kline & Company’s worst-case scenario – which it says is looking more and more likely – has the US cosmetics and personal-care market declining by as much as 8.1% in 2020. However, Kline, Mintel and other market intelligence firms say there are opportunities available to companies struggling to weather the COVID-19 storm.